Overview
Dr. Maisel, founder of the Retina Group of New York, is a board-certified ophthalmologist who completed the Dyson fellowship in Vitreous and Retinal surgery at New York Presbyterian Hospital-Cornell Medical Center. He has received a Special Congressional Award for his work in diabetic retinopathy and the Banko Gift of Sight Award. He also was named the Juvenile Diabetes Research Foundation Humanitarian of the Year.
He has served as a Corporate Advisory Board member for the Foundation of the American Academy of Ophthalmology (AAO) and the Juvenile Diabetes Foundation Medical Advisory Board. He was also a member of the AAO Instrument and Device and Low Vision Committees and has received research grants from the U.S. Public Health Service and the National Institute of Health. Dr. Maisel represented the National Society to Prevent Blindness at the ANSI Z-80 committee where he helped establish many ophthalmic industry standards. He served as an editor of EyeCare Technology Magazine and co-editor of Diabetes Technology Magazine. He also authored numerous professional journal articles and lectures nationally on the retina, medical informatics, and practice management topics. In addition, he has been a clinical investigator, consultant, educator, and advisory board member for Pfizer, Novartis, Genentech, Alimera, Regeneron, and Allergan, educating retinal specialists across the US.
Dr. Maisel specializes in diabetic retinopathy, macular degeneration, retinal tears and retinal detachment, macular pucker and macular hole repair, uveitis, ophthalmic surgical complications, hereditary retinal conditions, electrophysiology, glaucoma and second opinions.
Dr. Maisel is rated as an Experienced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Artery Occlusion, Cataract Removal, and Vitrectomy.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 S Oyster Bay Rd, 305, Hicksville, NY 11801
1455 Veterans Memorial Hwy, 100, Islandia, NY 11749
Additional Areas of Focus
Dr. Maisel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Vitreous Retina Macula Consultants Of New York
Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Vitreous Retina Macula Consultants Of New York(Downtown)
Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.
Kunal Dansingani is an Ophthalmologist in Hauppauge, New York. Dr. Dansingani is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Late-Onset Retinal DegenerationDr. Maisel isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Maisel isAdvanced. Learn about Retinal Artery Occlusion.
- Retinal Vein OcclusionDr. Maisel isAdvanced. Learn about Retinal Vein Occlusion.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Central Serous ChorioretinopathyDr. Maisel isExperienced. Learn about Central Serous Chorioretinopathy.
- Conjunctivitis (Pink Eye)Dr. Maisel isExperienced. Learn about Conjunctivitis (Pink Eye).
- Diabetic RetinopathyDr. Maisel isExperienced. Learn about Diabetic Retinopathy.
- EpiscleritisDr. Maisel isExperienced. Learn about Episcleritis.
- GlaucomaDr. Maisel isExperienced. Learn about Glaucoma.